Imugene Ltd Non-Deal Roadshow - Australia Transcript
Thank you, everyone, for attending. Some of you have been with the [share stock] since 2013, some of you came in at 2015 when I joined, then on and on, and just recently, so thank you so much. I consider some of you almost friends and family of Imugene because you've been in it maybe even longer than I have.
So 2013, Paul Hopper started this company. I joined roughly in 2015, straight from Genentech to San Francisco to Sydney and Imugene. I worked with Dr. Jakob Dupont. So it's gotten to a point where we're literally bringing in so many talented people. And one of the strict criteria that we have in our organization is that you have to be experts in your field, and Jacob definitely fills that role.
So 2015, I put my head down and developed our HER-Vaxx. Within five years, we were able to finish a Phase 2 study with overall survival data. Now in the field of oncology clinical development, that is lightning speed. You cannot imagine what it takes to take a drug into the clinic and then you hope for amazing data and you get it. So it's been a dream
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
